Abstract
Purpose To develop and evaluate a flexible, software-defined radar platform for contactless, vendor-independent motion detection and correction in MRI.
Methods A continuous-wave (CW) Doppler radar was implemented using a software-defined radio and the open-source GNU Radio framework. The system was deployed inside a 1.5T MRI scanner and synchronized with MRI acquisitions. We evaluated the performance in a custom-developed internal motion phantom and in healthy volunteers to track respiration and bulk motion. The radar-derived signal was validated against cine MRI and used to demonstrate both retrospective and prospective motion management techniques in phantom and in healthy volunteers.
Results The radar provided robust motion signals that correlated strongly with image-based ground truth signals in both phantom and volunteer experiments. Signal characteristics were found to be frequency-dependent, enabling optimization for different motion regimes. Retrospective correction of free-breathing abdominal data using the radar signal effectively suppressed respiratory artifacts, achieving image quality comparable to a self-gating approach. Prospective triggering successfully reduced motion artifacts in the phantom study. The system also reliably detected sporadic events such as swallowing during neck imaging.
Conclusion Software-defined radar was demonstrated to be an effective platform for both prospective and retrospective motion correction. Its independence from the MRI system, ultra-wide band capabilities, and body-region versatility enable the adaptation of the technique for a wide range of imaging applications and protocols.
Competing Interest Statement
H.C. reports research support (hardware and software) from Siemens Healthineers under a master research agreement and participation in the Siemens Healthineers speaker bureau. K.T.B. and H.C. report royalties from United Imaging for licensing GRASP. All other authors authors declare no competing interests.
Funding Statement
This work was performed under the rubric of the Center for Advanced Imaging Innovation and Research (CAI2R, www.cai2r.net), an NIBIB National Center for Biomedical Imaging and Bioengineering (NIH P41 EB017183). C.M. received funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), grant no. 512359237.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of NYU Langone Health gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
Software and data used in the phantom experiments are currently being prepared for public release and will be available following formal acceptance of the manuscript. Due to regulatory restrictions, volunteer data cannot be shared publicly.
